Making sense of the limb-girdle muscular dystrophies

Brain

Volumn 122, Issue 8, 1999, Pages 1403-1420

  Bushby, Katharine M D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Calpain; Dysferlin; LGMD; Limb girdle; Sarcoglycan

Indexed keywords

CALPAIN; DYSFERLIN; DYSTROPHIN; PROTEIN; SARCOGLYCAN; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; CLINICAL FEATURE; GENE LOCATION; GENETIC ANALYSIS; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MOLECULAR CLONING; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

CALPAIN; CHROMOSOME MAPPING; CYTOSKELETAL PROTEINS; DYSTROGLYCANS; GENES, RECESSIVE; HUMANS; ISOENZYMES; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES; PEPTIDE FRAGMENTS; SARCOGLYCANS;

EID: 0032855394     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.8.1403     Document Type: Review

References (129)

1. Achanzar WE, Ward S.A nematode gene required for sperm vesicle fusion. J Cell Sci 1997; 110: 1073-81.
2. Ahn AH, Freener CA, Gussoni E, Yoshida M, Ozawa E, Kunkel LM. The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives. J Biol Chem 1996; 271: 2724-30.
3. Allamand V, Broux O, Richard I, Fougerousse F, Chiannilkulchai N, Bourg N, et al. Preferential localization of the limb-girdle muscular dystrophy type 2A gene in the proximal part of a 1-cM 15q15.1-q15.3 interval [see comments]. Am J Hum Genet 1995; 56: 1417-30. Comment in: Am J Hum Genet 1996; 58: 241-3.
4. Allamand V, Broux O, Richard I, Fougerousse F, Chiannilkulchai N, Bourg N, et al. Preferential localization of the limb-girdle muscular dystrophy type 2A gene in the proximal part of a 1-cM 15q15.1-q15.3 interval [see comments]. Am J Hum Genet 1995; 56: 1417-30. Comment in: Am J Hum Genet 1996; 58: 241-3.
5. Anderson LVB. Optimized protein diagnosis in the autosomal recessive limb-girdle muscular dystrophies. Neuromuscul Disord 1996; 6: 443-6.
6. Anderson LVB, Davison K. Multiplex western blotting system for the analysis of muscular dystrophy proteins. Am J Pathol 1999; 154: 1017-22.
7. Anderson LVB, Davison K, Moss JA, Richard I, Fardeau M, Tome FMS, et al. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am J Pathol 1998; 153: 1169-79.
8. Anderson LVB, Davison K, Moss JA, Young K, Cullen MJ, Walsh J. Dysferlin is a plasma membrane protein and is expressed early in human development. Hum Mol Genet 1999; 8: 855-61.
9. Azibi K, Bachner L, Beckmann JS, Matsumura K, Hamouda E, Chaouch M, et al. Severe childhood autosomal recessive muscular dystrophy with the deficiency of the 50 kDa dystrophin-associated glycoprotein maps to chromosome 13q12. Hum Mol Genet 1993; 2: 1423-8.
10. Bashir R, Strachan T, Keers S, Stephenson A, Mahjneh I, Marconi G, et al. A gene for autosomal recessive limb-girdle muscular dystrophy maps to chromosome 2p. Hum Mol Genet 1994; 3: 455-7.
11. Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, Lako M, et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 1998; 20: 37-42.
12. Beckmann JS, Richard I, Hillaire D, Broux O, Antignac C, Bois E, et al. A gene for limb-girdle muscular dystrophy maps to chromosome 15 by linkage. C R Acad Sci Ser III 1991; 312: 141-8.
13. Beckmann J, Tomfordhe J, Barnes R, Williams M, Broux O, Richard I, et al. A linkage map of human chromosome 15 with an average resolution of 2 cM and containing 55 polymorphic microsatellites. Hum Mol Genet, 1993; 2: 2019-30.
14. Beckmann JS The Reunion paradox and the digenic model [letter; comment]. Am J Med Genet 1996; 59: 1400-2. Comment on: Am J Med Genet 1996; 58: 241-3.
15. Beckmann JS The Reunion paradox and the digenic model [letter; comment]. Am J Med Genet 1996; 59: 1400-2. Comment on: Am J Med Genet 1996; 58: 241-3.
16. Bejaoui K, Hirabayashi K, Hentati F, Haines JL, Ben Hamida C, Belal S, et al. Linkage of Miyoshi myopathy (distal autosomal recessive muscular dystrophy) locus to chromosome 2p12-14. Neurology 1995; 45: 768-72.
17. Ben Hamida M, Fardeau M, Attia N. Severe childhood muscular dystrophy affecting both sexes and frequent in Tunisia. Muscle Nerve 1983; 6: 469-80.
18. Bethlem J, Wijngaarden GK Benign myopathy, with autosomal dominant inheritance: a report on three pedigrees. Brain 1976; 99: 91-100.
19. Bonne G, Di Barletta MR, Varnous S, Becane H, Hammouda E, Urtizberea JA, et al. Genetic localisation of autosomal dominant Emery-Dreifuss muscular dystrophy [abstract]. Muscle Nerve 1998; Suppl 7: S65.
20. Bonnemann CG, Modi R, Noguchi S, Mizuno Y, Yoshida M, Gussoni E, et al. β-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex [published erratum appears in Nat Genet 1996; 12: 110]. Nat Genet 1995; 11: 266-73.
21. Bonnemann CG, Passos-Bueno MR, McNally EM, Vainzof M, de Sa Moreira E, Marie SK, et al. Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E). Hum Mol Genet 1996; 5: 1953-61.
22. Bushby K. Report on the 12th ENMC sponsored international workshop - the 'limb-girdle' muscular dystrophies. Neuromuscul Disord, 1992; 2: 3-5.
23. Bushby K, Beckmann JS. Report of the 30th and 31st ENMC international workshop - The limb-girdle muscular dystrophies -and proposal for a new nomenclature. Neuromuscul Disord 1995; 5: 337-43.
24. Bushby K, Anderson LVB, Sewry C, Pogue R, Taylor J, Pollitt C, et al. Dystrophinopathy or sarcoglycanopathy - the importance of a full diagnostic assessment in suspected manifesting carriers of Duchenne and Becker muscular dystrophy [abstract]. J Med Genet 1997; 34 Suppl 1: S54.
25. Bushby K, Anderson LV, Pollitt C, Naom I, Muntoni F, Bindoff L. Abnormal merosin in adults. A new form of late onset muscular dystrophy not linked to chromosome 6q2. Brain 1998; 121: 581-8.
26. Campbell KP. Adhalin gene mutations and autosomal recessive limb-girdle muscular dystrophy [editorial; comment). Ann Neurol 1995; 38: 353-354. Comment on: Ann Neurol 1995; 38: 367-72.
27. Campbell KP. Adhalin gene mutations and autosomal recessive limb-girdle muscular dystrophy [editorial; comment). Ann Neurol 1995; 38: 353-354. Comment on: Ann Neurol 1995; 38: 367-72.
28. Campbell KP, Kahl SD. Association of dystrophin and an integral membrane glycoprotein. Nature 1989; 338: 259-62.
29. Carrie A, Piccolo F, Leturcq F, de Toma C, Azibi K, Beldjord C, et al. Mutational diversity and hot spots in the α-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D). J Med Genet 1997; 34: 470-5.
30. Chiannilkulchai N, Pasturaud P, Richard I, Auffray C, Beckmann JS. A primary expression map of the chromosome 15q15 region containing the recessive form of limb-girdle muscular dystrophy (LGMD2A) gene. Hum Mol Genet 1995; 4: 717-25.
31. Cullen MJ, Walsh J, Roberds SL, Campbell KP Ultrastructural localisation of adhalin, α-dystroglycan and merosin in normal and dystrophic muscle. Neuropathol Applied Neurobiol 1996; 22: 30-7.
32. Dincer P, Leturcq F, Richard I, Piccolo F, Yalnizoglu D, de Toma C, et al. A biochemical, genetic and clinical survey of autosomal recessive limb girdle muscular dystrophy in Turkey. Ann Neurol 1997; 42: 222-9.
33. Duclos F, Broux O, Bourg N, Straub V, Feldman GL, Sunada Y, et al. β-sarcoglycan: genomic analysis and identification of a novel missense mutation in the LGMD2E Amish isolate. Neuromuscul Disord 1998; 8: 30-8.
34. Duggan DJ, Gorospe JR, Fanin M, Hoffman EP, Angelini C. Mutations in the sarcoglycan genes in patients with myopathy [see comments]. N Engl J Med 1997a; 336: 618-24. Comment in: N Engl J Med 1997; 336: 650-1.
35. Duggan DJ, Gorospe JR, Fanin M, Hoffman EP, Angelini C. Mutations in the sarcoglycan genes in patients with myopathy [see comments]. N Engl J Med 1997a; 336: 618-24. Comment in: N Engl J Med 1997; 336: 650-1.
36. Duggan DJ, Manchester D, Stears KP, Mathews DJ, Hart C, Hoffman EP. Mutations in the δ-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2). Neurogenetics 1997b; 1: 49-58.
37. Emery AE. Emery-Dreifuss syndrome. [Review]. J Med Genet 1989; 26: 637-41.
38. Eymard B, Romero NB, Leturcq F, Piccolo F, Carrie A, Jeanpierre M, et al. Primary adhalinopathy (α-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy. Neurology 1997; 48: 1227-34.
39. Fadic R, Sunada Y, Waclawik AJ, Buck S, Lewandoski PJ, Campbell KP, et al. Brief report: deficiency of a dystrophin-associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy [see comments]. N Engl J Med 1996; 334: 361-6. Comment in: N Engl J Med 1996; 334: 1610-1.
40. Fadic R, Sunada Y, Waclawik AJ, Buck S, Lewandoski PJ, Campbell KP, et al. Brief report: deficiency of a dystrophin-associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy [see comments]. N Engl J Med 1996; 334: 361-6. Comment in: N Engl J Med 1996; 334: 1610-1.
41. Fang W, Huang C, Chu N, Chen C, Lu CS, Wang CC. Childhood-onset autosomal-dominant limb-girdle muscular dystrophy with cardiac conduction block. Muscle Nerve 1997; 286-92.
42. Fanin M, Duggan DJ, Mostacciuolo ML, Martinello F, Freda MP, Soraru G, et al. Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations. J Med Genet 1997; 34: 973-7.
43. Fardeau M, Hillaire D, Mignard C, Feingold N, Feingold J, Mignard D, et al. Juvenile limb-girdle muscular dystrophy: clinical, histopathological and genetic data from a small community living in the Reunion Island. Brain 1996; 119: 295-308.
44. Fougerousse F, Broux O, Richard I, Allamand V, de Souza AP, Bourg N, et al. Mapping of a chromosome 15 region involved in limb girdle muscular dystrophy. Hum Mol Genet 1994; 3: 285-93.
45. Gilchrist JM, Pericak-Vance M, Silverman L, Roses AD. Clinical and genetic investigation in autosomal dominant limb-girdle muscular dystrophy. Neurology 1988; 38: 5-9.
46. Haiyashi YK, Mizuno Y, Yoshida M, Nonaka I, Ozawa E, Arahata K. The frequency of patients with 50-kd dystrophin-associated glycoprotein (50DAG or adhalin) deficiency in a muscular dystrophy patient population in Japan: immunocytochemical analysis of 50DAG, 43DAG, dystrophin and utrophin [see comments]. Neurology 1995; 45: 551-4. Comment in: Neurology 1995; 46: 1784-5.
47. Haiyashi YK, Mizuno Y, Yoshida M, Nonaka I, Ozawa E, Arahata K. The frequency of patients with 50-kd dystrophin-associated glycoprotein (50DAG or adhalin) deficiency in a muscular dystrophy patient population in Japan: immunocytochemical analysis of 50DAG, 43DAG, dystrophin and utrophin [see comments]. Neurology 1995; 45: 551-4. Comment in: Neurology 1995; 46: 1784-5.
48. Helbling-Leclerc A, Zhang X, Topaloglu H, Cruaud C, Tesson F, Weissenback J, et al. Mutations in the laminin alpha2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 1995; 11: 216-8.
49. Hillaire D, Leclerc A, Faure S, Topaloglu H, Chiannilkulchai N, Guicheney P, et al. Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet 1994; 3: 1657-61.
50. Illarioshkin SN, Ivanova-Smolenskaya IA, Tanaka H, Vereshchagin NV, Markova ED, Poleshchuk VV, et al. Clinical and molecular analysis of a large family with three distinct phenotypes of progressive muscular dystrophy. Brain 1996; 119: 1895-909.
51. Inoue M, Wakayama Y, Murahashi M, Shibuya S, Jimi T, Kojima H, et al. Electron microscopic observations of triple immunogold labelling for dystrophin, β-dystroglycan and adhalin in human skeletal myofibers. Acta Neuropathol (Berl) 1996; 92: 569-75.
52. Iwata Y, Pan Y, Hanada H, Yoshida T, Shigekawa M. Dystrophin-glycoprotein complex purified from hamster cardiac muscle. Comparison of the complexes from cardiac and skeletal muscles of hamster and rabbit. J Mol Cell Cardiol 1996; 28: 2501-9.
53. Jackson CE, Carey JH. Progressive muscular dystrophy: autosomal recessive type. Pediatrics 1961; 28: 77-84.
54. Jackson CE, Strehler DA. Limb-girdle muscular dystrophy: clinical manifestations and detection of preclinical disease. Pediatrics 1968; 41:495-502.
55. Jones KJ, Kim SS, North KN. Abnormalities of dystrophin, the sarcoglycans, and laminin α2 in the muscular dystrophies. J Med Genet 1998; 35: 379-86.
56. Kawai H, Akaike M, Endo T, Adachi K, Inui T, Mitsui T, et al. Adhalin gene mutations in patients with autosomal recessive childhood onset muscular dystrophy with adhalin deficiency. J Clin Invest 1995; 96: 1202-7.
57. Kinbara K, Sorimachi H, Ishiura S, Suzuki K. Muscle-specific calpain, p94, interacts with the extreme C-terminal region of connectin, a unique region flanked by two immunoglobulin C2 motifs. Arch Biochem Biophys 1997; 342: 99-107.
58. Lim LE, Duclos F, Broux O, Bourg N, Sunada Y, Allamand V, et al. β-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet 1995; 11: 257-65.
59. Linssen WH, Notermans NC, van der Graaf Y, Wokke JH, van Doom PA, Howeler CJ, et al. Miyoshi-type distal muscular dystrophy. Clinical spectrum in 24 Dutch patients. Brain 1997; 120: 1989-96.
60. Linssen WH, de Visser M, Notermans NC, Vreyling JP, van Doom PA, Wokke JH, et al. Genetic heterogeneity in Miyoshi-type distal muscular dystrophy. Neuromuscul Disord 1998; 8: 317-20.
61. Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C, et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998; 20: 31-6.
62. Ljunggren A, Duggan D, McNally E, Boylan KB, Gama CH, Kunkel LM, et al. Primary adhalin deficiency as a cause of muscular dystrophy in patients with normal dystrophin [see comments]. Ann Neurol 1995; 38: 367-72. Comment in: Ann Neurol 1995; 38: 353-4.
63. Ljunggren A, Duggan D, McNally E, Boylan KB, Gama CH, Kunkel LM, et al. Primary adhalin deficiency as a cause of muscular dystrophy in patients with normal dystrophin [see comments]. Ann Neurol 1995; 38: 367-72. Comment in: Ann Neurol 1995; 38: 353-4.
64. Madhavan R, Jarrett HW. Interactions between dystrophin glycoprotein complex proteins. Biochemistry 1995; 34: 12204-9.
65. Mahjneh I, Vannelli G, Bushby K, Marconi GP. A large inbred Palestinian family with two forms of muscular dystrophy. Neuromuscul Disord 1992; 2: 277-83.
66. Mahjneh I, Passos-Bueno MR, Zatz M, Vainzof M, Marconi G, Nashef L, et al. The phenotype of chromosome 2p-linked limb-girdle muscular dystrophy. Neuromuscul Disord 1996; 6: 483-90.
67. Malandrini A, Scarpini C, Fabrizi GM, Parrotta E, Salvadori C, Guazzi GC. Early-onset benign limb-girdle myopathy with contractures and facial involvement affecting a father and daughter. J Neurol Sci 1995; 132: 195-200.
68. Matsumura K, Campbell KP. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies [Review]. Muscle Nerve 1994; 17: 2-15.
69. McNally EM, Duggan D, Gorospe JR, Bonnemann CG, Fanin M, Pegoraro E, et al. Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy. Hum Mol Genet 1996; 5: 1841-7.
70. McNally EM, de Sa Moreira E, Duggan DJ, Bonnemann CG, Lisanti MP, Lidov HGW, et al. Caveolin-3 in muscular dystrophy. Hum Mol Genet, 1998a; 7: 871-7.
71. McNally EM, Ly CT, Kunkel LM. Human epsilon-sarcoglycan is highly related to α-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene. FEBS Lett 1998b; 422: 27-32.
72. Messina DN, Speer MC, Pericak-Vance MA, McNally EM. Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am J Hum Genet 1997; 61: 909-17.
73. Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M, et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 1998; 18: 365-8.
74. Moreira ES, Vainzof M, Marie SK, Sertie AL, Zatz M, Passos-Bueno MR. The seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q11-12. Am J Hum Genet 1997; 61: 151-9.
75. Nigro V, de Sa Moreira E, Piluso G, Vainzof M, Belsito A, Politano L, et al. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ-sarcoglycan gene. Nat Genet 1996; 14: 195-8.
76. Nigro V, Okazaki Y, Belsito A, Piluso G, Matsuda Y, Politano L, et al. Identification of the Syrian hamster cardiomyopathy gene. Hum Mol Genet 1997; 6: 601-7.
77. Noguchi S, McNally EM, Ben Othmane K, Hagiwara Y, Mizuno Y, Yoshida M, et al. Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy [see comments]. Science 1995; 270: 819-22. Comment in: Science 1995; 270: 755-6.
78. Noguchi S, McNally EM, Ben Othmane K, Hagiwara Y, Mizuno Y, Yoshida M, et al. Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy [see comments]. Science 1995; 270: 819-22. Comment in: Science 1995; 270: 755-6.
79. Norman A, Thomas N, Cockley J, Harper P Distinction of Becker from limb-girdle muscular dystrophy by means of dystrophin cDNA probes. Lancet 1989; 1: 466-8.
80. Ozawa E, Noguchi S, Mizuno Y, Hagiwara Y, Yoshida M. From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy. [Review]. Muscle Nerve 1998; 21: 421-38.
81. Passos-Bueno MR, Moreira ES, Marie SK, Bashir R, Vasquez L, Love DR, et al. Main clinical features of the three mapped autosomal recessive limb-girdle muscular dystrophies and estimated proportion of each form in 13 Brazilian families. J Med Genet 1996; 33: 97-102.
82. Passos-Bueno MR, Vainzof M, Moreira ES, Zatz M. The seven autosomal recessive limb-girdle muscular dystrophies (LGMD) in the Brazilian population from LGMD2A to LGMD2G. Am J Med Genet 1999; 82: 392-8.
83. Penisson-Besnier I, Richard I, Dubas F, Beckmann JS, Fardeau M. Pseudometabolic expression and phenotypic variability of calpain deficiency in two siblings. Muscle Nerve 1998; 21: 2078-80.
84. Philpot J, Sewry C, Pennock J, Dubowitz V. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromuscul Disord 1995; 5: 301-5.
85. Piccolo F, Roberds SL, Jeanpierre M, Leturcq F, Azibi K, Beldjord C, et al. Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity [published erratum appears in Nat Genet 1995; 11: 104]. Nat Genet 1995; 10: 243-5.
86. Piccolo F, Jeanpierre M, Leturcq F, Dode C, Azibi K, Toutain A, et al. A founder mutation in the γ-sarcoglycan gene of gypsies possibly predating their migration out of India. Hum Mol Genet 1996; 5: 2019-22.
87. Pogue R, West S, Bushby K. Multiplex SSCP and heteroduplex analysis with southern hybridisation for large-scale mutation detection: a new technique for the investigation of genetically heterogeneous disease, Genomics 1998; 54: 1-4.
88. Restagno G, Romero N, Richards I, Beckmann JS, Pagliano M, Ferrone M, et al. Prenatal diagnosis of limb-girdle muscular dystrophy type 2A. Neuromuscul Disord 1996; 6: 173-6.
89. Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, et al. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995; 81: 27-40.
90. Richard I, Brenguier L, Dincer P, Roudaut C, Bady B, Burgunder JM, et al. Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical origins. Am J Hum Genet 1997; 60: 1128-38.
91. Roberds SL, Leturcq F, Allamand V, Piccolo F, Jeanpierre M, Anderson RD, et al. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell 1994; 78: 625-33.
92. Romero NB, Tome FM, Leturcq F, el Kerch FE, Azibi K, Bachner L, et al. Genetic heterogeneity of severe childhood autosomal recessive muscular dystrophy with adhalin (50 kDa dystrophin-associated glycoprotein) deficiency. C R Acad Sci Ser III 1994; 317: 70-6.
93. Rudenskaya GE, Ginter EK, Petrin AN, Djomina NA. Emery-Dreifuss syndrome: genetic and clinical varieties. Am J Med Genet 1994; 50: 228-33.
94. Sakamoto A, Ono K, Abe M, Jasmin G, Eki T, Murakami Y, et al. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, δ-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci USA 1997; 94: 13873-8.
95. Sewry CA, Taylor J, Anderson LV, Ozawa E, Pogue R, Piccolo F, et al. Abnormalities in α-, β- and γ-sarcoglycan in patients with limb-girdle muscular dystrophy. Neuromuscul Disord 1996; 6: 467-74.
96. Shokeir MH, Kobrinsky NL Autosomal recessive muscular dystrophy in Manitoba Hutterites. Clin Genet 1976; 9: 197-202.
97. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, et al. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. J Biol Chem 1996; 271: 15160-5.
98. Sorimachi H, Suzuki K. Sequence comparison among muscle-specific calpain, p94, and calpain subunits. Biochim Biophys Acta 1992; 1160: 55-62.
99. Sorimachi H, Toyama-Sorimachi N, Saido TC, Kawasaki H, Sugita H, Miyasaka M, et al. Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J Biol Chem 1993; 268: 10593-605.
100. Sorimachi H, Kinbara K, Kimura S, Takahashi M, Ishiura S, Sasagawa N, et al. Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2a, associates with connectin through IS2, a p94-specific sequence. J Biol Chem 1995; 270: 31155-62.
101. Speer MC, Yamaoka LH, Gilchrist JM, Gaskell CP, Stajich JM, Vance JM, et al. Confirmation of genetic heterogeneity in limb-girdle muscular dystrophy: linkage of an autosomal dominant form to chromosome 5q. Am J Hum Genet 1992; 50: 1211-7.
102. Speer MC, Gilchrist JM, Stajich JM, Yamaoka LH, Westbrook CA, Pericak-Vance MA. Anticipation in autosomal dominant limb-girdle muscular dystrophy (LGMD1A) [abstract]. Am J Hum Genet 1994; 55 (3 Suppl): A7.
103. Spencer MJ, Tidball JG, Anderson LV, Bushby KM, Harris JB, Passos-Bueno MR, et al. Absence of calpain 3 in a form of limb-girdle muscular dystrophy (LGMD2A). J Neurol Sci 1997; 146: 173-8.
104. Straub V, Campbell KP. Muscular dystrophies and the dystrophin-glycoprotein complex. [Review]. Curr Opin Neurol 1997; 10: 168-75.
105. Taylor J, Muntoni F, Robb S, Dubowitz V, Sewry C. Early onset autosomal dominant myopathy with rigidity of the spine: a possible role for lammin beta-1? Neuromuscul Disord 1997; 7: 211-6.
106. Topaloglu H, Dincer P, Richard I, Akcoren Z, Alehan D, Ozme S, et al. Calpain-3 deficiency causes a mild muscular dystrophy in childhood. Neuropaediatrics 1997; 28: 212-6.
107. Upadhyaya M, Maynard J, Rogers MT, Lunt PW, Jardine P, Ravine D, et al. Improved molecular diagnosis of facioscapulohumeral muscular dystrophy (FSHD): validation of the differential double digestion for FSHD. J Med Genet 1997; 34: 476-9.
108. Urtasun M, Saenz A, Roudaut C, Poza JJ, Urtizberea JA, Cobo AM, et al. Limb-girdle muscular dystrophy in Guipuzcoa (Basque Country, Spain). Brain 1998; 121: 1735-47.
109. Vainzof M, Passos-Bueno MR, Canovas M, Moreira ES, Pavanello RC, Marie SK, et al. The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum Mol Genet 1996; 5: 1963-9.
110. van der Kooi AJ, de Visser M, Barth PG. Limb-girdle muscular dystrophy: reappraisal of a rejected entity. [Review]. Clin Neurol Neurosurgery 1994; 96: 209-18.
111. van der Kooi AJ, Ledderhof TM, de Voogt WG, Res CJ, Bouwsma G, Troost D, et al. A newly recognized autosomal dominant limb girdle muscular dystrophy with cardiac involvement. Ann Neurol 1996; 39: 636-42.
112. van der Kooi AJ, van Meegen M, Ledderhof TM, McNally EM, de Visser M, Bolhuis PA. Genetic localization of a newly recognized autosomal dominant limb-girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11-21. Am J Hum Genet 1997; 60: 891-5.
113. van der Kooi AJ, Ginjaar HB, Busch HF, Wokke JH, Barth PG, de Visser M. Limb girdle muscular dystrophy: a pathological and immunohistochemical re-evaluation. Muscle Nerve 1998a; 21: 584-90.
114. van der Kooi AJ, de Voost WG, Barth PG, Busch HF, Jennekens FG, Jongen PJ, et al. The heart in limb-girdle muscular dystrophy. Heart 1998b; 79: 73-7.
115. van Ommen GJ. A foundation for limb-girdle muscular dystrophy. Nat Med 1995; 1: 412-4.
116. Walton JN. On the inheritance of muscular dystrophy. Ann Hum Genet 1955; 20: 1-38.
117. Walton JN. The inheritance of muscular dystrophy: further observations. Ann J Hum Genet 1956; 21: 40-58.
118. Walton JN, Gardner-Medwin D. The muscular dystrophies. In: Walton JN, editor. Disorders of voluntary muscle. 5th ed. Edinburgh: Churchill Livingstone; 1991. p. 519-68.
119. Walton JN, Nattrass FJ. On the classification, natural history and treatment of the myopathies. Brain 1954; 77: 169-231.
120. Weiler T, Greenberg CR, Nylen E, Halliday W, Morgan K, Eggertson D, et al. Limb-girdle muscular dystrophy and Miyoshi myopathy in an Aboriginal Canadian kindred map to LGMD2B and segregate with the same haplotype. Am J Hum Genet 1996; 59: 872-8.
121. Weiler T, Greenberg CR, Zelinski T, Nylen E, Coghlan G, Crumley MJ, et al. A gene for autosomal recessive limb-girdle muscular dystrophy in Manitoba Hutterites maps to chromosome region 9q31-q33: evidence for another limb-girdle muscular dystrophy locus. Am J Hum Genet 1998; 63: 140-7.
122. Williamson RA, Henry MD, Daniels KJ, Hrstka RF, Lee JC, Sunada Y, et al. Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum Mol Genet 1997; 6: 831-41.
123. Worton R. Muscular dystrophies: diseases of the dystrophin-glycoprotein complex [comment]. [Review]. Science 1995; 270: 755-756. Comment on: Science 1995; 270: 819-22.
124. Worton R. Muscular dystrophies: diseases of the dystrophin-glycoprotein complex [comment]. [Review]. Science 1995; 270: 755-756. Comment on: Science 1995; 270: 819-22.
125. Yoshida M, Ozawa E. Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem (Tokyo) 1990; 108: 748-52.
126. Yoshida M, Suzuki A, Yamamoto H, Noguchi S, Mizuno Y, Ozawa E. Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-D-glucoside. Eur J Biochem 1994; 222: 1055-61.
127. Zlotogora J, Gieselmann V, Bach G. Multiple mutations in a specific gene in a small geographic area: a common phenomenon? [letter; comment] [see comments] Am J Hum Genet 1996; 58: 241-3. Comment on: Am J Hum Genet 1996; 56: 1417-30, Comment in: Am J Hum Genet 1996; 59: 1400-2.
128. Zlotogora J, Gieselmann V, Bach G. Multiple mutations in a specific gene in a small geographic area: a common phenomenon? [letter; comment] [see comments] Am J Hum Genet 1996; 58: 241-3. Comment on: Am J Hum Genet 1996; 56: 1417-30, Comment in: Am J Hum Genet 1996; 59: 1400-2.
129. Zlotogora J, Gieselmann V, Bach G. Multiple mutations in a specific gene in a small geographic area: a common phenomenon? [letter; comment] [see comments] Am J Hum Genet 1996; 58: 241-3. Comment on: Am J Hum Genet 1996; 56: 1417-30, Comment in: Am J Hum Genet 1996; 59: 1400-2.